Surya Singh, MD, is a highly experienced healthcare executive currently serving as CEO at InformedDNA and Senior Advisor at the Institute for Clinical and Economic Review. As President of Singh Healthcare Advisors, Surya Singh provides consultancy services focusing on medical policy, genomics, and product innovation. Previous roles include Co-Founder and CEO of gWell, Attending Physician at Brigham and Women's/Faulkner Hospitals, and Chief Medical Officer at CVS Health, where leadership was demonstrated in managing a significant specialty pharmacy division during rapid growth. Surya Singh's background also includes clinical product development as Chief Medical Officer at Proventys and D2Hawkeye, as well as engagement management at McKinsey and Company. Education includes an M.D. from The Johns Hopkins University School of Medicine and a BS in Molecular Biology from The University of Texas at Austin.